arGEN-X preclinical data

In a mouse model of CML, a murine formulation of 300 µg intraperitoneal ARGX-110 every 3 days plus Gleevec imatinib significantly increased mean overall survival (OS) vs. ARGX-110 alone, Gleevec alon...